The Michael J Fox Foundation for Parkinson’s Research invites pre-proposals for its target advancement programme. This supports research characterising promising, novel Parkinson’s disease-relevant targets or continuing target biology work on established PD targets. Preferred targets for this programme already demonstrate links to PD in human patient populations.
These awards are well-suited to projects where hypothetical or experimental rationale for a target is compelling but limited, and study results can make the case for continuing or discontinuing a line of research. Of particular interest are proposals that address emerging PD targets in pre-clinical models, human cellular models and human tissue and fluid matrices.
Collaborations are strongly encouraged.
Funding & Duration
Awards are worth up to USD $150,000 each (approx. AUD $202,000) over 12 to 18 months.
Applications may be submitted by researchers or clinicians in:
- U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
- U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
- Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research. The administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.
Submission Requirements & Due Dates
- 26 September 2018 – Pre-Proposals submitted to Sponsor
- 15 January 2018 – full applications submitted for internal review.
- Please complete your RFR through ResearchMaster > Fund Scheme code ORG122461
- See also: Submitting an Application to Research Services for Review